CA3079993A1 - Composition and method for germinative compounds in probiotic food and beverage products for human consumption - Google Patents
Composition and method for germinative compounds in probiotic food and beverage products for human consumption Download PDFInfo
- Publication number
- CA3079993A1 CA3079993A1 CA3079993A CA3079993A CA3079993A1 CA 3079993 A1 CA3079993 A1 CA 3079993A1 CA 3079993 A CA3079993 A CA 3079993A CA 3079993 A CA3079993 A CA 3079993A CA 3079993 A1 CA3079993 A1 CA 3079993A1
- Authority
- CA
- Canada
- Prior art keywords
- bacillus
- food
- tea
- beverage
- probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 116
- 239000006041 probiotic Substances 0.000 title claims abstract description 49
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 49
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 40
- 235000013305 food Nutrition 0.000 title claims abstract description 39
- 235000013361 beverage Nutrition 0.000 title claims abstract description 38
- 238000000034 method Methods 0.000 title claims abstract description 31
- 150000001875 compounds Chemical class 0.000 title description 6
- 235000013616 tea Nutrition 0.000 claims abstract description 42
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 241000894007 species Species 0.000 claims abstract description 16
- 150000008575 L-amino acids Chemical class 0.000 claims abstract description 11
- 239000000872 buffer Substances 0.000 claims abstract description 9
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 claims abstract description 8
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 7
- 235000014347 soups Nutrition 0.000 claims abstract description 7
- 235000015067 sauces Nutrition 0.000 claims abstract description 6
- 244000269722 Thea sinensis Species 0.000 claims description 52
- 239000000047 product Substances 0.000 claims description 25
- 241000194108 Bacillus licheniformis Species 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 11
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 8
- 229910001414 potassium ion Inorganic materials 0.000 claims description 8
- 244000063299 Bacillus subtilis Species 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 235000013882 gravy Nutrition 0.000 claims description 6
- 235000020278 hot chocolate Nutrition 0.000 claims description 6
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 5
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- 229960003767 alanine Drugs 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 4
- 241000194105 Paenibacillus polymyxa Species 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 241000193749 Bacillus coagulans Species 0.000 claims description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 3
- 241000193752 Bacillus circulans Species 0.000 claims description 2
- 241001328122 Bacillus clausii Species 0.000 claims description 2
- 241000193747 Bacillus firmus Species 0.000 claims description 2
- 241000021612 Bacillus halotolerans Species 0.000 claims description 2
- 241000193422 Bacillus lentus Species 0.000 claims description 2
- 241000194107 Bacillus megaterium Species 0.000 claims description 2
- 241000671023 Bacillus olivae Species 0.000 claims description 2
- 241000194103 Bacillus pumilus Species 0.000 claims description 2
- 241000193400 Bacillus simplex Species 0.000 claims description 2
- 241000266830 Bacillus sonorensis Species 0.000 claims description 2
- 241000193388 Bacillus thuringiensis Species 0.000 claims description 2
- 241000193417 Brevibacillus laterosporus Species 0.000 claims description 2
- 241000193386 Lysinibacillus sphaericus Species 0.000 claims description 2
- 241000881860 Paenibacillus mucilaginosus Species 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- 241001464969 Sporolactobacillus laevolacticus Species 0.000 claims description 2
- 229960001230 asparagine Drugs 0.000 claims description 2
- 229940054340 bacillus coagulans Drugs 0.000 claims description 2
- 229940005348 bacillus firmus Drugs 0.000 claims description 2
- 239000007633 bacillus mucilaginosus Substances 0.000 claims description 2
- 229940097012 bacillus thuringiensis Drugs 0.000 claims description 2
- 239000000413 hydrolysate Substances 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- RDZTWEVXRGYCFV-UHFFFAOYSA-M sodium 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonate Chemical compound [Na+].OCCN1CCN(CCS([O-])(=O)=O)CC1 RDZTWEVXRGYCFV-UHFFFAOYSA-M 0.000 claims description 2
- 229940001941 soy protein Drugs 0.000 claims description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims 2
- 235000021474 generally recognized As safe (food) Nutrition 0.000 claims 2
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 claims 2
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims 1
- 235000011164 potassium chloride Nutrition 0.000 claims 1
- 239000001103 potassium chloride Substances 0.000 claims 1
- 229960004295 valine Drugs 0.000 claims 1
- 230000003213 activating effect Effects 0.000 abstract description 4
- 235000016213 coffee Nutrition 0.000 abstract description 3
- 235000013353 coffee beverage Nutrition 0.000 abstract description 3
- 210000004215 spore Anatomy 0.000 description 94
- 238000009472 formulation Methods 0.000 description 38
- 235000015097 nutrients Nutrition 0.000 description 37
- 241000894006 Bacteria Species 0.000 description 10
- 230000035784 germination Effects 0.000 description 7
- 239000001488 sodium phosphate Substances 0.000 description 6
- 238000011534 incubation Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- 235000009569 green tea Nutrition 0.000 description 4
- 244000005702 human microbiome Species 0.000 description 4
- 235000020279 black tea Nutrition 0.000 description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 description 3
- 235000019800 disodium phosphate Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 3
- 235000019799 monosodium phosphate Nutrition 0.000 description 3
- 238000002135 phase contrast microscopy Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 3
- 230000004763 spore germination Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- WQXNXVUDBPYKBA-UHFFFAOYSA-N Ectoine Natural products CC1=NCCC(C(O)=O)N1 WQXNXVUDBPYKBA-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 210000004666 bacterial spore Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000006177 biological buffer Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 244000005709 gut microbiome Species 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- -1 but not limited to Proteins 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000021268 hot food Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 235000019226 kombucha tea Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000021489 probiotic drink Nutrition 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N3/00—Spore forming or isolating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/10—Bacillus licheniformis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Husbandry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Tea And Coffee (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Fruits And Vegetables (AREA)
Abstract
A composition and method for activating probiotic spores in food and beverage products, such as steeped teas, coffee, soups, and sauces. A nutrient-germinant composition comprises one or more L-amino acids, optionally one or more buffers to maintain the pH of the composition when added to water in a range of around 6-8, optionally D-glucose, D-fructose, or both D-glucose and D-fructose, and optionally, an osmoprotectant. The nutrient-germinant composition, one or more species of Bacillus spores, and a food or beverage product may be pre-mixed in any combination. Water is added to the mixture and heated to a temperature range of 42 to 100°C to germinate the probiotic spores prior to being consumed.
Description
COMPOSITION AND METHOD FOR GERMINATIVE COMPOUNDS
IN PROBIOTIC FOOD AND BEVERAGE PRODUCTS FOR HUMAN CONSUMPTION
CROSS REFERENCE TO RELATED APPLICATION
[0001] This application claims the benefit of U.S. Provisional Patent Application No. 62/581,324 filed on November 3, 2017. This application also claims the benefit of U.S. Provisional Patent Application No. 62/596,424 filed on December 8, 2017.
BACKGROUND
IN PROBIOTIC FOOD AND BEVERAGE PRODUCTS FOR HUMAN CONSUMPTION
CROSS REFERENCE TO RELATED APPLICATION
[0001] This application claims the benefit of U.S. Provisional Patent Application No. 62/581,324 filed on November 3, 2017. This application also claims the benefit of U.S. Provisional Patent Application No. 62/596,424 filed on December 8, 2017.
BACKGROUND
[0002] Recent scientific advances have shed light on the significance of the relationship between human gut bacteria (the microbiome) and general health.
The human microbiome is a product of our genetics, our diets, and our environment.
Probiotics may be used to alter the human microbiome. Probiotics for human consumption are available as capsules and as food products (e.g. yogurt, beverages, etc.). Although there are examples of probiotic tea on the market, there are none that include an activating component to germinate probiotic spores for improved efficacy.
Here, an invention is described that includes the provision of activating compounds with Bacillus bacterial spores for human probiotic consumption in tea, soups, gravies, sauces, hot chocolate, and other food and beverage products, particularly heated liquids and fluids.
BRIEF DESCRIPTION OF THE FIGURES
The human microbiome is a product of our genetics, our diets, and our environment.
Probiotics may be used to alter the human microbiome. Probiotics for human consumption are available as capsules and as food products (e.g. yogurt, beverages, etc.). Although there are examples of probiotic tea on the market, there are none that include an activating component to germinate probiotic spores for improved efficacy.
Here, an invention is described that includes the provision of activating compounds with Bacillus bacterial spores for human probiotic consumption in tea, soups, gravies, sauces, hot chocolate, and other food and beverage products, particularly heated liquids and fluids.
BRIEF DESCRIPTION OF THE FIGURES
[0003] The system and method of the invention are further described and explained in relation to the following drawing wherein:
FIG. 1 shows photographs of Bacillus species in a nutrient germinant composition according to a preferred embodiment at time zero (when hot water is initially added) and after steeping in hot water for 60 minutes at various temperatures according to preferred methods of the invention, the darker spots indicate germinated bacteria and the lighter/brighter spot indicate non-germinated spores;
FIG. 2 shows photographs of Bacillus species and a nutrient germinant composition according to a preferred embodiment in steeped tea (black and green tea) according to a preferred method of the invention, the darker spots indicate germinated bacteria and the lighter/brighter spots indicate non-germinated spores.
DETAILED DESCRIPTION
FIG. 1 shows photographs of Bacillus species in a nutrient germinant composition according to a preferred embodiment at time zero (when hot water is initially added) and after steeping in hot water for 60 minutes at various temperatures according to preferred methods of the invention, the darker spots indicate germinated bacteria and the lighter/brighter spot indicate non-germinated spores;
FIG. 2 shows photographs of Bacillus species and a nutrient germinant composition according to a preferred embodiment in steeped tea (black and green tea) according to a preferred method of the invention, the darker spots indicate germinated bacteria and the lighter/brighter spots indicate non-germinated spores.
DETAILED DESCRIPTION
[0004] Recent scientific advances have shed light on the significance of the relationship between human gut bacteria (the microbiome) and overall health.
The human microbiome is a product of our genetics, our diets, and our environment.
Probiotics may be used to alter the human microbiome in order to regulate the digestive system and bolster the immune system. Generally, probiotics are non-pathogenic bacteria that may include species of lactic acid bacteria (Lactobacillus), Bifidobacterium, and Propionibacterium. Species of Bacillus are also common as probiotics.
Probiotics have been widely used in animals as an alternative to hormones and antibiotics, in plants to enhance certain growth characteristics, and in humans as a digestive supplement. Probiotics for human consumption are available as capsules and as food products (e.g. yogurt, juice, etc.). Probiotics delivered in tea are also on the market.
Probiotic tea products contain probiotic bacteria packaged with tea in a porous bag. Tea bags are steeped for a period of time in hot water and are consumed.
Alternatively, Kombucha tea is a type of probiotic drink in which a symbiotic culture of bacteria and yeast (SCOBY) is added to tea containing sugar. The SCOBY then acts to ferment the sugar in the tea to produce vitamins and acids. In this case, the sugar acts as a substrate and the drink does not contain amino acids that are known to activate bacteria.
The human microbiome is a product of our genetics, our diets, and our environment.
Probiotics may be used to alter the human microbiome in order to regulate the digestive system and bolster the immune system. Generally, probiotics are non-pathogenic bacteria that may include species of lactic acid bacteria (Lactobacillus), Bifidobacterium, and Propionibacterium. Species of Bacillus are also common as probiotics.
Probiotics have been widely used in animals as an alternative to hormones and antibiotics, in plants to enhance certain growth characteristics, and in humans as a digestive supplement. Probiotics for human consumption are available as capsules and as food products (e.g. yogurt, juice, etc.). Probiotics delivered in tea are also on the market.
Probiotic tea products contain probiotic bacteria packaged with tea in a porous bag. Tea bags are steeped for a period of time in hot water and are consumed.
Alternatively, Kombucha tea is a type of probiotic drink in which a symbiotic culture of bacteria and yeast (SCOBY) is added to tea containing sugar. The SCOBY then acts to ferment the sugar in the tea to produce vitamins and acids. In this case, the sugar acts as a substrate and the drink does not contain amino acids that are known to activate bacteria.
[0005] In the case of Bacillus species as probiotics (e.g. B. coagulans), the bacteria are supplied as spores. Spores represent a unique life stage of specific species of bacteria in that these species have the ability to transition into a dormant spore stage if environmental conditions are unfavorable. Spores are naturally dehydrated, are stable for extended periods of time, and are resistant to environmental stresses (e.g. heat, salt, pH, etc.). In the case of Bacillus spores in tea products, the spores are preferably more resistant to the high temperatures of steeping water.
[0006] In order for spores to return to a live, vegitatively growing state, they must first germinate. Spore germination is a multistep process in which spores are revived from the dormant state. The first step is one by which spores are activated and are induced to germinate, typically by an environmental signal called a germinant.
This signal can be a nutrient such as an L-amino acid, potassium ions (e.g. KCI), and/or natural osmoprotectant compounds (e.g. ectoine). Nutrient germinants bind to receptors in the inner-membrane of the spore to initiate germination. Additionally, sugars have been shown to increase the binding affinity of L-amino acids for their cognate receptors.
This signal can be a nutrient such as an L-amino acid, potassium ions (e.g. KCI), and/or natural osmoprotectant compounds (e.g. ectoine). Nutrient germinants bind to receptors in the inner-membrane of the spore to initiate germination. Additionally, sugars have been shown to increase the binding affinity of L-amino acids for their cognate receptors.
[0007] The germinant signal initiates an irreversible cascade of events, also known as commitment. Commitment is fast and is typically >90% complete in 2 minutes.
As germination progresses, the spore rapidly takes on water. As the spore absorbs water it consequently loses its refractivity. This loss of refractivity towards the end of the first phase in the germination process allows spore germination to be observed via phase-contrast microscopy. The initial phase is typically complete within 30 to 60 minutes depending on the temperature. The second phase of germination is an outgrowth step in which the spore's metabolic, biosynthetic, and DNA
replication/repair pathways initiate. The outgrowth period includes a ripening period in which no morphological changes (such as cell growth) occur, but the spore's molecular machinery (e.g. transcription factors, translation machinery, biosynthesis machinery, etc.) is activated. This period can vary in length based on the initial resources that are packaged with the spore during the process of sporulation.
As germination progresses, the spore rapidly takes on water. As the spore absorbs water it consequently loses its refractivity. This loss of refractivity towards the end of the first phase in the germination process allows spore germination to be observed via phase-contrast microscopy. The initial phase is typically complete within 30 to 60 minutes depending on the temperature. The second phase of germination is an outgrowth step in which the spore's metabolic, biosynthetic, and DNA
replication/repair pathways initiate. The outgrowth period includes a ripening period in which no morphological changes (such as cell growth) occur, but the spore's molecular machinery (e.g. transcription factors, translation machinery, biosynthesis machinery, etc.) is activated. This period can vary in length based on the initial resources that are packaged with the spore during the process of sporulation.
[0008] It is known that spores can be induced to germinate via heat-activation.
Spores of various Bacillus species have been heat-activated at strain specific temperatures (e.g. B. subtilis spores can be heat-activated at 75 C for 30 minutes while B. licheniformis spores can be heat-activated at 65 C for 20 minutes). The heat-activation is believed to cause a transient, reversible unfolding of spore proteins. If the spore proteins are not presented with a nutrient germinant, such as L-alanine, they will refold and effectively reverse the germination process.
Spores of various Bacillus species have been heat-activated at strain specific temperatures (e.g. B. subtilis spores can be heat-activated at 75 C for 30 minutes while B. licheniformis spores can be heat-activated at 65 C for 20 minutes). The heat-activation is believed to cause a transient, reversible unfolding of spore proteins. If the spore proteins are not presented with a nutrient germinant, such as L-alanine, they will refold and effectively reverse the germination process.
[0009] The present invention describes a composition and method for activating probiotic spores in in food and beverage products, such as steeped teas, soups, gravies, sauces, hot chocolate, coffee, and other products, particularly heated liquids and fluids. The method includes the provision of nutrient germinants with Bacillus spores that will be heat activated and subsequently germinated with nutrient germ inants while the food or beverage product is being heated, such as while tea is steeping in hot water. According to one preferred embodiment, the two probiotic components (bacterial spores and nutrient germinants) may be provided as dry components in an automatic coffee maker pod (e.g. Keurig , Nespresso , Tassimo , etc.) containing tea or another food or beverage product. According to another preferred embodiment, the ingredients may be provided as mixed ingredients (nutrient germinant composition and spores) in a single serve packet to be added to tea or another food or beverage product, mixed components (nutrient germinant composition and spores) in a single bag containing tea or another food or beverage product, or as separated components in separate tea bags (e.g. two bags containing any combination of the nutrient germinant composition, spores, and tea) or other container for other food or beverage products.
According to one preferred embodiment, spores can be heat-activated in the presence of nutrient germinants in a method that is described in U.S. Patent Application No 15/479,773, which is incorporated herein by reference.
According to one preferred embodiment, spores can be heat-activated in the presence of nutrient germinants in a method that is described in U.S. Patent Application No 15/479,773, which is incorporated herein by reference.
[0010] Nutrient Compositions
[0011] Described herein are preferred embodiments of nutrient compositions that may contain one or more L-amino acids, D-glucose, D-fructose, a biological buffer, a potassium ion source, and/or a natural osmoprotectant. All components in the nutrient formulation must be Generally Regarded as Safe (GRAS) for human consumption by the United States Food and Drug Administration. At the time of this writing, most, although not all, of the components described herein have been deemed GRAS.
[0012] According to one preferred embodiment, the nutrient germinant composition can include one or more L-amino acids. Preferred L-amino acid(s) included in the nutrient formulation are L-alanine, L-asparagine, L- valine, and/or L-cysteine. The choice of L-amino acids is determined by the species of Bacillus used in the probiotic formulation. The L-amino acids can be provided in the form of any suitable source, such as their pure forms and/or a hydrolysate of soy protein.
[0013] According to another preferred embodiment, the nutrient germinant composition can optionally contain an amount of D-glucose and/or D-fructose.
The choice of sugar is determined by the species of Bacillus used in the probiotic formulation.
The choice of sugar is determined by the species of Bacillus used in the probiotic formulation.
[0014] According to another preferred embodiment, the nutrient germinant composition can optionally contain one or more sources of potassium ions.
Preferably, KCI can be included as a source of potassium ions in the nutrient formulation.
The inclusion of potassium ions is determined by the species of Bacillus used in the probiotic formulation.
Preferably, KCI can be included as a source of potassium ions in the nutrient formulation.
The inclusion of potassium ions is determined by the species of Bacillus used in the probiotic formulation.
[0015] According to another preferred embodiment, the nutrient germinant composition can optionally contain one or more biological buffers. The biologic buffer is a buffer that can buffer the nutrient formulation and/or nutrient-spore formulation, to maintain the formulation at the proper pH for spore germination (about pH 6-8).
Preferred biologic buffers include, but are not limited to, a phosphate buffer or a HEPES
sodium salt. According to another preferred embodiment, monosodium phosphate and disodium phosphate, preferably used together, can be included in the nutrient formulation as buffers. According to another preferred embodiment, a HEPES
buffer may be used.
Preferred biologic buffers include, but are not limited to, a phosphate buffer or a HEPES
sodium salt. According to another preferred embodiment, monosodium phosphate and disodium phosphate, preferably used together, can be included in the nutrient formulation as buffers. According to another preferred embodiment, a HEPES
buffer may be used.
[0016] According to another preferred embodiment, the nutrient solution can optionally contain an osmoprotectant compound. Preferably, ectoine, a natural osmoprotectant produced by some species of bacteria, may be included. The inclusion of an osmoprotectant is determined by the species of Bacillus used in the probiotic formulation.
[0017] According to another preferred embodiment, the nutrient composition is any one of the nutrient compositions described in U.S. Patent Application No 15/479,773.
[0018] According to yet another preferred embodiment, a nutrient composition may contain ingredients in one or more of the above-reference categories of ingredients and may contain one or more ingredients from within those categories.
[0019] Spore Formulations
[0020] Preferred embodiments of spore formulations include one or more Bacillus species of spores, including but not limited to, Bacillus licheniformis, Bacillus subtiffis, Bacillus amyloliquiefaciens, Bacillus polymyxa, Bacillus thuringiensis, Bacillus megaterium, Bacillus coagulans, Bacillus lentus, Bacillus clausii, Bacillus circulans, Bacillus firmus, Bacillus lactis, Bacillus laterosporus, Bacillus laevolacticus, Bacillus polymyxa, Bacillus pumilus, Bacillus simplex, Bacillus sphaericus, Bacillus sonorensis, Bacillus, homeckiae, Bacillus axarquiensis, Bacillus mucilaginosus, Bacillus olivae, and any combinations thereof. All strains in the probiotic formulation must be Generally Regarded as Safe (GRAS) for human consumption by the United States Food and Drug Administration. At the time of filing this application, several, although not all, of the above mentioned strains have been deemed GRAS. Any Bacillus species subsequently determined to be GRAS are included here as suitable for use with embodiments of the invention.
[0021] Preferred spore formulations can contain 1-20 or more species of Bacillus spores. According to one preferred embodiment, a spore formulation can contain 3 strains of Bacillus bacteria. According to another preferred embodiment, 2 strains of the Bacillus bacteria can each be a different strain of the species Bacillus licheniformis and the third strain is a species of Bacillus subtilis.
According to another preferred embodiment, about 80% of the formulation can be Bacillus licheniformis (40%
of each strain) and 20% of the spores in the spore formulation can be is Bacillus subtilis.
According to another preferred embodiment, the spores of the strain(s) included in the spore formulation can be mixed with water or other suitable carrier and/or organic salts.
According to another preferred embodiment, about 80% of the formulation can be Bacillus licheniformis (40%
of each strain) and 20% of the spores in the spore formulation can be is Bacillus subtilis.
According to another preferred embodiment, the spores of the strain(s) included in the spore formulation can be mixed with water or other suitable carrier and/or organic salts.
[0022] Most preferably, the Bacillus species that can be contained in the spore formulations can produce and/or be capable of producing one or more enzymes including, but not limited to, proteases, amylases, lipases, glycosidases, cellulases, esterases, and xylanases. Tests and assays for determining the production of such enzymes from a Bacillus species are generally known in the art and to one of ordinary skill in the art.
[0023] According to one preferred embodiment, the spore formulation can contain about 0.1% to 90% by weight spores, along with salt or other suitable carrier, such as sodium bicarbonate, or maltodextrin, or a combination thereof. In some embodiments, the spore formulation contains about 5% by weight spores. The spore formulation can be and/or include a powder or other dry form (e.g. spray-dried form of a liquid spore concentrate, or lyophilized spore formulation) containing spores.
According to another preferred embodiment, the total concentration of spores in the spore formulation can range from about 1 x 105 CFU/mL or spores/g to 1 x 1014 CFU/mL
or spores/g or any specific concentration or range therein. The total preferred concentration of spores in the spore formulation can be about 1, 1.125, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.25, 5.5, 5.75, 6, 6.25, 6.5, 6.75, 7, 7.25, 7.5, 7.75, 8, 8.25, 8.5, 8.75, 9, 9.25, 9.5, or 9.75 x 105, 106, 107, 108, 109, 1010 , 1011, 1012, 1013, or 1014 CFU/mL or spores/g or any range or other value therein.
According to another preferred embodiment, any one specific spore species can be present in the spore formulation at a concentration that can range from about 1 x 105 CFU/mL to 1 x 1014 CFU/mL or any specific range therein. The preferred concentration of any one specific spore species present in the preferred embodiments of spore formulations according to the invention can be about 1, 1.125, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.25, 5.5, 5.75, 6, 6.25, 6.5, 6.75, 7, 7.25, 7.5, 7.75, 8, 8.25, 8.5, 8.75, 9, 9.25, 9.5, or 9.75 x 105, 106, 107, 108, 109, 1010, 1011, 1012, 1013, or 1014 CFU/mL or spores/g or any range or other value therein.
Preferably, the spore formulation is biodegradable. According to another preferred embodiment, the concentrated spore formulation can contain about 1-9 x 109 or 1010 CFU/mL or spores/g.
According to another preferred embodiment, the concentrated spore formulation can contain about 1010 CFU/mL or spores/g.
According to another preferred embodiment, the total concentration of spores in the spore formulation can range from about 1 x 105 CFU/mL or spores/g to 1 x 1014 CFU/mL
or spores/g or any specific concentration or range therein. The total preferred concentration of spores in the spore formulation can be about 1, 1.125, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.25, 5.5, 5.75, 6, 6.25, 6.5, 6.75, 7, 7.25, 7.5, 7.75, 8, 8.25, 8.5, 8.75, 9, 9.25, 9.5, or 9.75 x 105, 106, 107, 108, 109, 1010 , 1011, 1012, 1013, or 1014 CFU/mL or spores/g or any range or other value therein.
According to another preferred embodiment, any one specific spore species can be present in the spore formulation at a concentration that can range from about 1 x 105 CFU/mL to 1 x 1014 CFU/mL or any specific range therein. The preferred concentration of any one specific spore species present in the preferred embodiments of spore formulations according to the invention can be about 1, 1.125, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.25, 5.5, 5.75, 6, 6.25, 6.5, 6.75, 7, 7.25, 7.5, 7.75, 8, 8.25, 8.5, 8.75, 9, 9.25, 9.5, or 9.75 x 105, 106, 107, 108, 109, 1010, 1011, 1012, 1013, or 1014 CFU/mL or spores/g or any range or other value therein.
Preferably, the spore formulation is biodegradable. According to another preferred embodiment, the concentrated spore formulation can contain about 1-9 x 109 or 1010 CFU/mL or spores/g.
According to another preferred embodiment, the concentrated spore formulation can contain about 1010 CFU/mL or spores/g.
[0024] According to one preferred embodiment of a probiotic tea composition, the composition comprises a nutrient composition, a spore formulation, and tea.
According to another preferred embodiment or a probiotic composition for human consumption, the composition comprises a nutrient composition, a spore formulation, and a food or beverage product, such as soups, gravies, sauces, hot chocolate.
Most preferably, the nutrient composition and spore formulation in these embodiments are one of the above described embodiments, both in dry powdered or other dry solid form.
Any variety of tea or other food or beverage product may be used. Most preferably, the food or beverage product is one that is heated before being consumed.
According to another preferred embodiment or a probiotic composition for human consumption, the composition comprises a nutrient composition, a spore formulation, and a food or beverage product, such as soups, gravies, sauces, hot chocolate.
Most preferably, the nutrient composition and spore formulation in these embodiments are one of the above described embodiments, both in dry powdered or other dry solid form.
Any variety of tea or other food or beverage product may be used. Most preferably, the food or beverage product is one that is heated before being consumed.
[0025] According to one preferred method of providing probiotic tea for human consumption, a nutrient composition and spore formulation are added to any variety of tea. Most preferably, the nutrient composition and spore formulation are one of the above described embodiments. According to one preferred embodiment, the nutrient composition, spore formulation, and tea or other food or beverage product are combined into a mixture prior to steeping in hot water or otherwise heating the food or beverage product. According to other preferred embodiments, the nutrient composition, spore formulation, and tea may be separate components that are added together to hot water to prepare the probiotic tea or added to the other food or beverage product to be heated or already heated, or any combination of two of the components may be pre-mixed together and added to the third component prior to or after adding hot water to prepare the probiotic tea or prior to or after heating the other food or beverage product.
The order of addition of the three components and the hot water or hot food or beverage is not critical and any order may be used. When used for tea, after mixing or adding the three components, individually or as a pre-mixed combination, with hot water, the mixture is allowed to steep, preferably for 2 to 10 minutes prior to being consumed by a human. Two minutes is the preferred minimum amount of steeping time, but the total time may vary based on the type of tea used and the strength of the tea desired by the person who will consume the probiotic tea. For example, green tea is typically steeped for 2-4 minutes while Oolong tea is typically steeped for 5-8 minutes.
Consumption is preferably by drinking or otherwise orally ingesting the probiotic tea. Most preferably, the hot water is at a temperature in the range of 42 to 100 C when initially added to the other components. The hot water temperature is preferably not below 42 C, and the range may vary based on the type of tea being used. For example, green tea is typically steeped in the range of 65-80 C and black tea is usually steeped in the range of 80-100 C.
The order of addition of the three components and the hot water or hot food or beverage is not critical and any order may be used. When used for tea, after mixing or adding the three components, individually or as a pre-mixed combination, with hot water, the mixture is allowed to steep, preferably for 2 to 10 minutes prior to being consumed by a human. Two minutes is the preferred minimum amount of steeping time, but the total time may vary based on the type of tea used and the strength of the tea desired by the person who will consume the probiotic tea. For example, green tea is typically steeped for 2-4 minutes while Oolong tea is typically steeped for 5-8 minutes.
Consumption is preferably by drinking or otherwise orally ingesting the probiotic tea. Most preferably, the hot water is at a temperature in the range of 42 to 100 C when initially added to the other components. The hot water temperature is preferably not below 42 C, and the range may vary based on the type of tea being used. For example, green tea is typically steeped in the range of 65-80 C and black tea is usually steeped in the range of 80-100 C.
[0026] Various compositions according to preferred embodiments of the invention were tested according to preferred methods of the invention.
The compositions, methods, and results are described below.
The compositions, methods, and results are described below.
[0027] EXAMPLE 1 ¨ A probiotic blend of Bacillus spores (B. subtilis and B.
licheniformis) at a final concentration of approx. 4 x 106 CFU/mL, where CFU
stands for colony forming unit, and a nutrient germinant composition according to a preferred embodiment of the invention comprising L-alanine (0.21g), monosodium phosphate (0.14g), and disodium phosphate (0.5g), were added to approx. 8 fluid ounces of tap water at various temperatures.
licheniformis) at a final concentration of approx. 4 x 106 CFU/mL, where CFU
stands for colony forming unit, and a nutrient germinant composition according to a preferred embodiment of the invention comprising L-alanine (0.21g), monosodium phosphate (0.14g), and disodium phosphate (0.5g), were added to approx. 8 fluid ounces of tap water at various temperatures.
[0028] The amount of spores added represents a "dose" of 109 CFU of probiotic bacteria, as recommended by a Harvard Health study. The amount of nutrient germinants used represents the minimum concentration of germinants necessary to initiate germination. The temperatures used represent a range of tea steeping temperatures.
[0029] Spores from each reaction were observed at time 0 and after 60 minutes using phase contrast microscopy. Slides were prepared using standard procedures.
Spores were viewed on an Olympus BX41 microscope (100X oil emersion objective) and imaged using an Olympus UC30 camera controlled by the cellSens Dimension software package.
Spores were viewed on an Olympus BX41 microscope (100X oil emersion objective) and imaged using an Olympus UC30 camera controlled by the cellSens Dimension software package.
[0030] FIG. 1 shows representative images from these tests at time 0 (i.e.
immediately after water addition) and after 60 minutes in the water. The darker spots show germinated spores, the lighter spots show non-germinated spores. The images in group A represent spores that had been germinated using a nutrient-germ inant composition and heated during the incubation period at 42 C according to a preferred composition and preferred method of the invention. The images in group B
represent spores that had been germinated using a nutrient-germinant composition and heated during the incubation period at 65 C according to a preferred composition and preferred method of the invention. The images in group C represent spores that had been germinated using a nutrient-germinant composition and heated during the incubation period at 75 C according to a preferred composition and preferred method of the invention. The images in group D represent spores that had been germinated using a nutrient-germinant composition and heated during the incubation period at 85 C
according to a preferred composition and preferred method of the invention.
The images in group E represent represents spores that had been germinated using a nutrient-germinant composition and heated during the incubation period at 100 C
according to a preferred composition and preferred method of the invention.
immediately after water addition) and after 60 minutes in the water. The darker spots show germinated spores, the lighter spots show non-germinated spores. The images in group A represent spores that had been germinated using a nutrient-germ inant composition and heated during the incubation period at 42 C according to a preferred composition and preferred method of the invention. The images in group B
represent spores that had been germinated using a nutrient-germinant composition and heated during the incubation period at 65 C according to a preferred composition and preferred method of the invention. The images in group C represent spores that had been germinated using a nutrient-germinant composition and heated during the incubation period at 75 C according to a preferred composition and preferred method of the invention. The images in group D represent spores that had been germinated using a nutrient-germinant composition and heated during the incubation period at 85 C
according to a preferred composition and preferred method of the invention.
The images in group E represent represents spores that had been germinated using a nutrient-germinant composition and heated during the incubation period at 100 C
according to a preferred composition and preferred method of the invention.
[0031] Taken together, these images show that Bacillus spores are germinated in the compositions and conditions of preferred embodiments of the present invention.
[0032] EXAMPLE 2 ¨ A probiotic blend of Bacillus spores (B. subtilis and B.
licheniformis) at a final concentration of approx. 4 x 106 CFU/mL and a nutrient germinant composition, according to a preferred embodiment of the invention, comprising L-alanine (0.21g), monosodium phosphate (0.14g), and disodium phosphate (0.5g), were added to approx. 8 fluid ounces of tap water at 85 C. A tea bag containing the indicated variety of tea (black or green as shown in FIG. 2) was steeped in the water for approx. 3 minutes, as recommended by the tea manufacturer. After steeping, the tea bags were removed while the spores remained in the mixture to be ingested as a probiotic dose.
licheniformis) at a final concentration of approx. 4 x 106 CFU/mL and a nutrient germinant composition, according to a preferred embodiment of the invention, comprising L-alanine (0.21g), monosodium phosphate (0.14g), and disodium phosphate (0.5g), were added to approx. 8 fluid ounces of tap water at 85 C. A tea bag containing the indicated variety of tea (black or green as shown in FIG. 2) was steeped in the water for approx. 3 minutes, as recommended by the tea manufacturer. After steeping, the tea bags were removed while the spores remained in the mixture to be ingested as a probiotic dose.
[0033] Spores from each reaction were observed after 60 minutes using phase contrast microscopy. Slides were prepared using standard procedures. Spores were viewed on an Olympus BX41 microscope (100X oil emersion objective) and imaged using an Olympus UC30 camera controlled by the cellSens Dimension software package.
[0034] FIG. 2 shows representative images from these tests after 60 minutes in the water. The darker spots show germinated spores, the lighter/brighter spots show non-germinated spores. The top images represent spores germinated in steeped black tea (Lipton TM) while the bottom images represent spores germinated in steeped green tea (Bigelow ).
[0035] Taken together, these images show that Bacillus spores are germinated in the compositions and conditions of preferred embodiments of the present invention and that compounds that are extracted from tea during steeping do not abate the germination process.
[0036] Although the above examples are in reference to use of probiotic compositions with tea, the compositions and methods of the invention may be used with other types of food or beverage products, such as soups, gravies, or hot chocolate.
Most preferably, such food and beverage products are liquids or fluids and are consumed after heating, but other types of food and beverage products may also be used.
Most preferably, such food and beverage products are liquids or fluids and are consumed after heating, but other types of food and beverage products may also be used.
[0037] All amounts for ingredients or ratios of ingredients indicated herein as a range include each individual amount or ratio within those ranges and any and all subset combinations within ranges, including subsets that overlap from one preferred range to a more preferred range. Those of ordinary skill in the art will appreciate upon reading this specification, including the examples contained herein, that modifications and alterations to the composition and methodology for making the composition may be made within the scope of the invention and it is intended that the scope of the invention disclosed herein be limited only by the broadest interpretation of the appended claims to which the inventor is legally entitled.
Claims (17)
1. A probiotic food or beverage composition for human consumption, the composition comprising:
one or more species of Bacillus in spore form;
one or more L-amino acids;
any variety of liquid or fluid food or beverage product;
optionally one or more buffers to maintain the pH of the composition when added to water in a range of around 6-8;
optionally D-glucose, D-fructose, or both D-glucose and D-fructose;
optionally, an osmoprotectant optionally a source of potassium ions; and wherein all ingredients are GRAS.
one or more species of Bacillus in spore form;
one or more L-amino acids;
any variety of liquid or fluid food or beverage product;
optionally one or more buffers to maintain the pH of the composition when added to water in a range of around 6-8;
optionally D-glucose, D-fructose, or both D-glucose and D-fructose;
optionally, an osmoprotectant optionally a source of potassium ions; and wherein all ingredients are GRAS.
2. The probiotic food or beverage composition according to claim 1 wherein the one or more the L-amino acids is L-alanine, L-asparagine, L-valine, L-cysteine, a hydrolysate of soy protein, or a combination thereof.
3. The probiotic food or beverage composition according to claim 2 wherein the composition comprises at least one of the optional ingredients.
4. The probiotic food or beverage composition according to claim 2 wherein the composition comprises at least two of the optional ingredients.
5. The probiotic food or beverage composition according to claim 2 wherein the buffer is a phosphate buffer or HEPES sodium salt.
6. The probiotic food or beverage composition according to claim 2 wherein the source of potassium ions is potassium chloride.
7. The probiotic food or beverage composition according to claim 2 wherein the Bacillus species are one or more of Bacillus licheniformis, Bacillus subtillis, Bacillus amyloliquiefaciens, Bacillus polymyxa, Bacillus thuringiensis, Bacillus megaterium, Bacillus coagulans, Bacillus lentus, Bacillus clausii, Bacillus circulans, Bacillus firmus, Bacillus lactis, Bacillus laterosporus, Bacillus laevolacticus, Bacillus polymyxa, Bacillus pumilus, Bacillus simplex, Bacillus sphaericus, Bacillus sonorensis, Bacillus, horneckiae, Bacillus axarquiensis, Bacillus mucilaginosus, Bacillus olivae
8. The probiotic food or beverage composition according to claim 2 wherein the Bacillus species are Bacillus licheniformis, or Bacillus subtilis, or a combination thereof.
9. The probiotic food or beverage composition according to claim 8 wherein the Bacillus species are two different strains of Bacillus licheniformis and at least one strain of Bacillus subtilis.
10. The probiotic food or beverage composition according to claim 9 wherein the Bacillus species comprises around 40% of a first strain of Bacillus licheniformis, around 40% of a second strain of Bacillus licheniformis, and around 20% of the at least one strain of Bacillus subtilis.
11. The probiotic food or beverage composition according to claim 1 wherein the food or beverage is any variety of tea, hot chocolate, soup, gravy, or sauce.
12. A method of preparing a probiotic food or beverage for human consumption, the method comprising:
providing a first component comprising one or more species of Bacillus in spore form;
providing a second component comprising one or more L-amino acids; optionally one or more buffers to maintain the pH of the composition when added to water in a range of around 6-8; optionally D-glucose, D-fructose, or both D-glucose and D-fructose; optionally a source of potassium ions; and providing a third component comprising any food or beverage product;
mixing the first, second, and third components and heating or adding hot water;
and wherein all ingredients in each of the components are GRAS.
providing a first component comprising one or more species of Bacillus in spore form;
providing a second component comprising one or more L-amino acids; optionally one or more buffers to maintain the pH of the composition when added to water in a range of around 6-8; optionally D-glucose, D-fructose, or both D-glucose and D-fructose; optionally a source of potassium ions; and providing a third component comprising any food or beverage product;
mixing the first, second, and third components and heating or adding hot water;
and wherein all ingredients in each of the components are GRAS.
13. The method of claim 12 further comprising pre-mixing the first, second, and third components to form a pre-mixture wherein the third component is any variety of tea;
placing the pre-mixture in a water permeable bag;
placing the bag into a container with hot water;
allowing the first, second, and third components to steep in the hot water to produce a drinkable tea; and removing the bag after the drinkable tea is produced.
placing the pre-mixture in a water permeable bag;
placing the bag into a container with hot water;
allowing the first, second, and third components to steep in the hot water to produce a drinkable tea; and removing the bag after the drinkable tea is produced.
14. The method of claim 12 further comprising pre-mixing the first, second, and third components to form a pre-mixture wherein the third component is any variety of tea;
placing the pre-mixture in a first container configured to allow hot water to enter the first container, steep the components to form the drinkable tea, and allowing the drinkable tea to pass through the first container into a second container.
placing the pre-mixture in a first container configured to allow hot water to enter the first container, steep the components to form the drinkable tea, and allowing the drinkable tea to pass through the first container into a second container.
15. The method of claim 12 wherein the hot water is in a temperature range of 42 to 100°C.
16. The method of claim 12 wherein the components steep in the hot water for 2 to minutes prior to being consumed by a human.
17. The method of claim 12 wherein the food or beverage is any variety of tea, hot chocolate, soup, gravy, or sauce that is heated to a temperature range of 42 to 100°C prior to being consumed.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762581324P | 2017-11-03 | 2017-11-03 | |
US62/581,324 | 2017-11-03 | ||
US201762596424P | 2017-12-08 | 2017-12-08 | |
US62/596,424 | 2017-12-08 | ||
PCT/US2018/058944 WO2019090065A1 (en) | 2017-11-03 | 2018-11-02 | Composition and method for germinative compounds in probiotic food and beverage products for human consumption |
Publications (2)
Publication Number | Publication Date |
---|---|
CA3079993A1 true CA3079993A1 (en) | 2019-05-09 |
CA3079993C CA3079993C (en) | 2022-09-20 |
Family
ID=66333644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3079993A Active CA3079993C (en) | 2017-11-03 | 2018-11-02 | Composition and method for germinative compounds in probiotic food and beverage products for human consumption |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP3703721A4 (en) |
CN (1) | CN111295197A (en) |
BR (1) | BR112020008712A2 (en) |
CA (1) | CA3079993C (en) |
CO (1) | CO2020006844A2 (en) |
MX (1) | MX2020004473A (en) |
PH (1) | PH12020550820A1 (en) |
WO (1) | WO2019090065A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2018012060A (en) * | 2016-04-05 | 2019-03-06 | Nch Corp | Nutrient rich germinant composition and spore incubation method. |
US12097226B2 (en) | 2016-04-05 | 2024-09-24 | Nch Corporation | System and method for using a single-serve nutrient spore composition for small scale farm applications |
CN109182204A (en) * | 2018-10-09 | 2019-01-11 | 揭阳市腾晟科技咨询有限公司 | A kind of microbe leaven and preparation method thereof |
US11576937B2 (en) | 2020-02-06 | 2023-02-14 | Nch Corporation | Method of reducing gut inflammation reduction in humans by consuming a heated probiotic composition |
WO2021194930A1 (en) * | 2020-03-23 | 2021-09-30 | Nch Corporation | System and method for using a single-serve nutrient spore composition for small scale farm applications |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6327965B1 (en) * | 2000-07-03 | 2001-12-11 | Yu-Mei Lin Tien | Safety and drain-preventing infusing tea maker |
CN101636173A (en) * | 2007-03-27 | 2010-01-27 | 宝洁公司 | Methods and kits for administering probiotics |
CA2702668C (en) * | 2007-10-16 | 2015-12-29 | Ganeden Biotech, Inc. | Beverage compositions |
PT2954041T (en) * | 2013-02-06 | 2018-10-22 | Envera Llc | Dried spore germinative compound mixtures |
MX2018012060A (en) * | 2016-04-05 | 2019-03-06 | Nch Corp | Nutrient rich germinant composition and spore incubation method. |
-
2018
- 2018-11-02 MX MX2020004473A patent/MX2020004473A/en unknown
- 2018-11-02 CA CA3079993A patent/CA3079993C/en active Active
- 2018-11-02 WO PCT/US2018/058944 patent/WO2019090065A1/en active Application Filing
- 2018-11-02 CN CN201880071014.9A patent/CN111295197A/en active Pending
- 2018-11-02 BR BR112020008712-2A patent/BR112020008712A2/en not_active Application Discontinuation
- 2018-11-02 EP EP18873222.6A patent/EP3703721A4/en active Pending
-
2020
- 2020-05-03 PH PH12020550820A patent/PH12020550820A1/en unknown
- 2020-06-02 CO CONC2020/0006844A patent/CO2020006844A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3703721A4 (en) | 2021-12-22 |
MX2020004473A (en) | 2020-08-03 |
WO2019090065A8 (en) | 2019-06-06 |
EP3703721A1 (en) | 2020-09-09 |
WO2019090065A1 (en) | 2019-05-09 |
CN111295197A (en) | 2020-06-16 |
BR112020008712A2 (en) | 2020-11-03 |
CA3079993C (en) | 2022-09-20 |
CO2020006844A2 (en) | 2020-08-21 |
PH12020550820A1 (en) | 2021-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA3079993C (en) | Composition and method for germinative compounds in probiotic food and beverage products for human consumption | |
US20190069587A1 (en) | Composition and Method for Germinative Compounds in Probiotic Food and Beverage Products for Human Consumption | |
CN102006787B (en) | Long-life probiotic food product | |
AU2022235541A1 (en) | Composition suitable for protecting microorganisms | |
Forssten et al. | Probiotics from an industrial perspective | |
CN101664215B (en) | Compound beverage containing probiotics and collagen and preparation method thereof | |
CN103189499B (en) | Lactic acid bacteria and/or the Agent for improvement in survival of bacillus bifidus | |
CN1622815B (en) | Immune stimulating substance including methane nutrition bacteria biomass | |
AU2010209806A1 (en) | Composition comprising caftaric acid and/or derivatives thereof | |
CN102123615A (en) | Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract | |
CN104411186A (en) | Concentrated low water activity liquid human milk fortifier including extensively hydrolyzed protein | |
TW201300526A (en) | Method for manufacturing culture medium, and culture medium manufactured by method | |
Sheth et al. | Recent advancements in the production of probiotic fermented beverages | |
JP7312447B2 (en) | Method for producing lactic acid fermented food | |
Maity et al. | Alkalihalobacillus clausii 088AE as a functional and medical food ingredient: assessment of in vitro protein digestibility and food calorie reduction | |
CN109527268A (en) | A kind of production method of slow-release probiotics shrimp feed | |
WO2021159068A1 (en) | Composition and method of using germinative compounds in probiotics for inflammation reduction in humans | |
Hati et al. | Encapsulation of probiotics for enhancing the survival in gastrointestinal tract | |
Mohkam et al. | Role of bacillus genus in the production of value-added compounds | |
CN116963607A (en) | Use of lactic acid bacteria to inhibit methanogenic bacteria growth or reduce methane emissions | |
WO2020158737A1 (en) | Probiotic composition imparted with storage stability and stability against gastric juice decomposition | |
RU2415922C1 (en) | Nutrient medium for lactic acid bacilli cultivation | |
US20080044398A1 (en) | Soluble composition having enzymatic activity and improved stability | |
CN106858040A (en) | High content reduced glutathione Cultures of S. cerevisiae and its production method | |
Satwong et al. | Feasibility study on co‐culture Bacillus coagulans and Lacticaseibacillus rhamnosus formulated in probiotic‐supplemented pigmented rice products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20211130 |
|
EEER | Examination request |
Effective date: 20211130 |
|
EEER | Examination request |
Effective date: 20211130 |
|
EEER | Examination request |
Effective date: 20211130 |